Phenserine - Next Generation AChE Inhibitor for Alzheimer's Disease (AD)

 

Key Data:

Drug (brand / generic)
Phenserine
Company / licensee
Axonyx
Therapy class
AChE inhibitor
Product description
Dual-acting AChE inhibitor and anti-amyloid agent
Current indication
Alzheimer's disease
Market sector
CNS
Development status
Phase II / III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development